Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis.

scientific article

Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1019671818
P356DOI10.1097/01.LAB.0000067481.08984.3F
P698PubMed publication ID12746473

P50authorGyeong Hoon KangQ56613348
Hwoon-Yong JungQ57766691
P2093author name stringSun Lee
Gyeong Hoon Kang
Jung-Sun Kim
P433issue5
P921main subjectCpG islandQ1138360
carcinogenesisQ1637543
P304page(s)635-641
P577publication date2003-05-01
P1433published inLaboratory InvestigationQ6467260
P1476titleProfile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric Carcinogenesis
Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis.
P478volume83

Reverse relations

cites work (P2860)
Q49360423Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
Q82539025Accumulation of DNA methylation is associated with tumor stage in gastric cancer
Q36477008Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population
Q54961446Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis.
Q44952417Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis
Q38082475Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir
Q36837622Colorectal cancer: molecular mutations and polymorphisms
Q84075262Correlation of epigenetic aberrance with STAT3 signaling pathway in gastric carcinogenesis
Q43274890CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma
Q36343388CpG island hypermethylation in gastric carcinoma and its premalignant lesions
Q36346096CpG island hypermethylation in progression of esophageal and gastric cancer
Q36654458DNA and histone methylation in gastric carcinogenesis
Q34603514DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Q34447242DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation
Q61865601DNA methylation profile during multistage progression of pulmonary adenocarcinomas
Q38229830DNA methylation, ageing and the influence of early life nutrition
Q36986433DNA methylation: its role in cancer development and therapy
Q36819379Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer
Q37245723Disappearance of Serum Methylated p16 Indicates Longer Survival in Patients with Gastric Cancer
Q64904776Downregulation of Friend Leukemia Integration 1 (FLI1) follows the stepwise progression to gastric adenocarcinoma.
Q42684127Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer
Q38110164Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk
Q28070086Epigenetic roles in the malignant transformation of gastric mucosal cells
Q34504229Epstein-Barr virus-specific methylation of human genes in gastric cancer cells
Q42277869Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers
Q26753852Gastric cancer development after the successful eradication of Helicobacter pylori
Q40760600Helicobacter, Inflammation, and Gastric Cancer
Q40106497High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.
Q35973274Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis
Q33645099Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
Q34528757Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
Q34349990Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa
Q58698615Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis
Q35572461Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Q38830059Non-homologous end joining induced alterations in DNA methylation: A source of permanent epigenetic change.
Q55040764Opinion: Bacterial toxins and cancer--a case to answer?
Q36616006Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
Q38550277Premalignant lesions in gastric cancer
Q90233808Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
Q37338112Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis
Q90164570Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
Q51891134Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells.
Q37240404p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
Q33553893p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma

Search more.